This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fernandez, M.
Right arrow Articles by Baker, C. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fernandez, M.
Right arrow Articles by Baker, C. J.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 1998, p. 1517-1519, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis

Marisol Fernandez,* Melissa E. Hickman, and Carol J. Baker

Section of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030

Received 25 July 1997/Returned for modification 16 March 1998/Accepted 23 March 1998

In vitro testing of 229 group B streptococcal isolates from a variety of patients with invasive infections indicated uniform penicillin G susceptibility. However, 17 (7.4%) isolates were resistant to erythromycin and 8 (3.4%) were resistant to clindamycin. These results support the continued use of penicillin G as the drug of choice for the treatment and prevention of group B streptococcal disease.

* Corresponding author. Mailing address: Department of Pediatrics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030. Phone: (713) 798-4790. Fax: (713) 798-6407. E-mail: cbaker{at}bcm.tmc.edu.

Antimicrobial Agents and Chemotherapy, June 1998, p. 1517-1519, Vol. 42, No. 6
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Nagano, N., Nagano, Y., Kimura, K., Tamai, K., Yanagisawa, H., Arakawa, Y. (2008). Genetic Heterogeneity in pbp Genes among Clinically Isolated Group B Streptococci with Reduced Penicillin Susceptibility. Antimicrob. Agents Chemother. 52: 4258-4267 [Abstract] [Full Text]  
  • Puopolo, K. M., Klinzing, D. C., Lin, M. P., Yesucevitz, D. L., Cieslewicz, M. J. (2007). A composite transposon associated with erythromycin and clindamycin resistance in group B Streptococcus. J Med Microbiol 56: 947-955 [Abstract] [Full Text]  
  • Metsvaht, T., Oselin, K., Ilmoja, M.-L., Anier, K., Lutsar, I. (2007). Pharmacokinetics of Penicillin G in Very-Low-Birth-Weight Neonates. Antimicrob. Agents Chemother. 51: 1995-2000 [Abstract] [Full Text]  
  • Honest, H., Sharma, S., Khan, K. S. (2006). Rapid Tests for Group B Streptococcus Colonization in Laboring Women: A Systematic Review. Pediatrics 117: 1055-1066 [Abstract] [Full Text]  
  • Dogan, B., Schukken, Y. H., Santisteban, C., Boor, K. J. (2005). Distribution of Serotypes and Antimicrobial Resistance Genes among Streptococcus agalactiae Isolates from Bovine and Human Hosts. J. Clin. Microbiol. 43: 5899-5906 [Abstract] [Full Text]  
  • von Both, U., Buerckstuemmer, A., Fluegge, K., Berner, R. (2005). Heterogeneity of Genotype-Phenotype Correlation among Macrolide-Resistant Streptococcus agalactiae Isolates. Antimicrob. Agents Chemother. 49: 3080-3082 [Abstract] [Full Text]  
  • Cheng, Q., Nelson, D., Zhu, S., Fischetti, V. A. (2005). Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic Enzyme. Antimicrob. Agents Chemother. 49: 111-117 [Abstract] [Full Text]  
  • Fluegge, K., Supper, S., Siedler, A., Berner, R. (2004). Antibiotic Susceptibility in Neonatal Invasive Isolates of Streptococcus agalactiae in a 2-Year Nationwide Surveillance Study in Germany. Antimicrob. Agents Chemother. 48: 4444-4446 [Abstract] [Full Text]  
  • Uh, Y., Jang, I. H., Hwang, G. Y., Lee, M. K., Yoon, K. J., Kim, H. Y. (2004). Serotypes and Genotypes of Erythromycin-Resistant Group B Streptococci in Korea. J. Clin. Microbiol. 42: 3306-3308 [Abstract] [Full Text]  
  • Bingen, E., Doit, C., Bidet, P., Brahimi, N., Deforche, D. (2004). Telithromycin Susceptibility and Genomic Diversity of Macrolide-Resistant Serotype III Group B Streptococci Isolated in Perinatal Infections. Antimicrob. Agents Chemother. 48: 677-680 [Abstract] [Full Text]  
  • d'Oliveira, R. E.C., Barros, R. R., Mendonca, C. R.V., Teixeira, L. M., Castro, A. C.D. (2003). Susceptibility to antimicrobials and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae from Rio de Janeiro, Brazil. J Med Microbiol 52: 1029-1030 [Full Text]  
  • Lopardo, H. A., Vidal, P., Jeric, P., Centron, D., Paganini, H., Facklam, R. R., Elliott, J. (2003). Six-Month Multicenter Study on Invasive Infections Due to Group B Streptococci in Argentina. J. Clin. Microbiol. 41: 4688-4694 [Abstract] [Full Text]  
  • Werno, A. M., Anderson, T. P., Murdoch, D. R. (2003). Antimicrobial Susceptibilities of Group B Streptococci in New Zealand. Antimicrob. Agents Chemother. 47: 2710-2711 [Full Text]  
  • von Both, U., Ruess, M., Mueller, U., Fluegge, K., Sander, A., Berner, R. (2003). A Serotype V Clone Is Predominant among Erythromycin-Resistant Streptococcus agalactiae Isolates in a Southwestern Region of Germany. J. Clin. Microbiol. 41: 2166-2169 [Abstract] [Full Text]  
  • Baker, C J, Edwards, M S (2003). Group B streptococcal conjugate vaccines. Arch. Dis. Child. 88: 375-378 [Abstract] [Full Text]  
  • Betriu, C., Culebras, E., Gomez, M., Rodriguez-Avial, I., Sanchez, B. A., Agreda, M. C., Picazo, J. J. (2003). Erythromycin and Clindamycin Resistance and Telithromycin Susceptibility in Streptococcus agalactiae. Antimicrob. Agents Chemother. 47: 1112-1114 [Abstract] [Full Text]  
  • Poyart, C., Jardy, L., Quesne, G., Berche, P., Trieu-Cuot, P. (2003). Genetic Basis of Antibiotic Resistance in Streptococcus agalactiae Strains Isolated in a French Hospital. Antimicrob. Agents Chemother. 47: 794-797 [Abstract] [Full Text]  
  • Lefort, A., Lortholary, O., Casassus, P., Selton-Suty, C., Guillevin, L., Mainardi, J.-L., for the ss-Hemolytic Streptococci Infective Endoca, (2002). Comparison Between Adult Endocarditis Due to {beta}-Hemolytic Streptococci (Serogroups A, B, C, and G) and Streptococcus milleri: A Multicenter Study in France. Arch Intern Med 162: 2450-2456 [Abstract] [Full Text]  
  • Reinscheid, D. J., Stosser, C., Ehlert, K., Jack, R. W., Moller, K., Eikmanns, B. J., Chhatwal, G. S. (2002). Influence of proteins Bsp and FemH on cell shape and peptidoglycan composition in group B streptococcus. Microbiology 148: 3245-3254 [Abstract] [Full Text]  
  • (2002). Prevention of group B streptococcal infection in newborns: Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ 166: 928-930 [Full Text]  
  • de Azavedo, J. C. S., McGavin, M., Duncan, C., Low, D. E., McGeer, A. (2001). Prevalence and Mechanisms of Macrolide Resistance in Invasive and Noninvasive Group B Streptococcus Isolates from Ontario, Canada. Antimicrob. Agents Chemother. 45: 3504-3508 [Abstract] [Full Text]  
  • Murdoch, D. R., Reller, L. B. (2001). Antimicrobial Susceptibilities of Group B Streptococci Isolated from Patients with Invasive Disease: 10-Year Perspective. Antimicrob. Agents Chemother. 45: 3623-3624 [Abstract] [Full Text]  
  • Hsueh, P.-R., Teng, L.-J., Lee, L.-N., Ho, S.-W., Yang, P.-C., Luh, K.-T. (2001). High Incidence of Erythromycin Resistance among Clinical Isolates of Streptococcus agalactiae in Taiwan. Antimicrob. Agents Chemother. 45: 3205-3208 [Abstract] [Full Text]  
  • Paoletti, L. C., Rench, M. A., Kasper, D. L., Molrine, D., Ambrosino, D., Baker, C. J. (2001). Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate Vaccines. Infect. Immun. 69: 6696-6701 [Abstract] [Full Text]  
  • Matsubara, K., Nishiyama, Y., Katayama, K., Yamamoto, G., Sugiyama, M., Murai, T., Baba, K. (2001). Change of antimicrobial susceptibility of group B streptococci over 15 years in Japan. J Antimicrob Chemother 48: 579-582 [Abstract] [Full Text]  
  • Fitoussi, F., Loukil, C., Gros, I., Clermont, O., Mariani, P., Bonacorsi, S., Le Thomas, I., Deforche, D., Bingen, E. (2001). Mechanisms of Macrolide Resistance in Clinical Group B Streptococci Isolated in France. Antimicrob. Agents Chemother. 45: 1889-1891 [Abstract] [Full Text]  
  • Baker, C. J. (2000). Prophylactic antibiotic use leads to drop in early-onset GBS cases. AAP News 17: 154-154 [Full Text]  
  • Del Vecchio, M. T., Sundel, E. R., Benstock, M. A., Berger Sadow, K., Teach, S. J. (2000). Choice of Antibiotics in Febrile Neonates. Arch Pediatr Adolesc Med 154: 205-206 [Full Text]  
  • Schrag, S. J., Zywicki, S., Farley, M. M., Reingold, A. L., Harrison, L. H., Lefkowitz, L. B., Hadler, J. L., Danila, R., Cieslak, P. R., Schuchat, A. (2000). Group B Streptococcal Disease in the Era of Intrapartum Antibiotic Prophylaxis. NEJM 342: 15-20 [Abstract] [Full Text]  
  • Scanziani, R., Dozio, B., Baragetti, I., Grillo, P., Colombo, L., De Liso, S., Surian, M. (1999). Vaginal colonization with group B Streptococcus (Streptococcus agalactiae) and peritonitis in a woman on CAPD. Nephrol Dial Transplant 14: 2222-2224 [Full Text]  
  • Sadow, K. B., Derr, R., Teach, S. J. (1999). Bacterial Infections in Infants 60 Days and Younger: Epidemiology, Resistance, and Implications for Treatment. Arch Pediatr Adolesc Med 153: 611-614 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»